Request Deal Involvement

Rock Springs Capital led a $95m Series C round in Xilio Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Holland & Knight

legal advisors

Holland & Knight

or

Principals

RIVERVEST VENTURE PARTNERS

bidder

RIVERVEST VENTURE PARTNERS

ROCK SPRINGS CAPITAL

bidder

ROCK SPRINGS CAPITAL

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

XILIO THERAPEUTICS

target

XILIO THERAPEUTICS

DEERFIELD MANAGEMENT COMPANY

bidder

DEERFIELD MANAGEMENT COMPANY

SV HEALTH INVESTORS

bidder

SV HEALTH INVESTORS

TAKEDA VENTURES

bidder

TAKEDA VENTURES

MRL VENTURES FUND

bidder

MRL VENTURES FUND

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Rock Springs Capital led a $95m Series C round in Xilio Therapeutics.